Literature DB >> 9040036

Coronary endothelial dysfunction precedes heart failure and reduction of coronary reserve in awake dogs.

M Knecht1, D Burkhoff, G H Yi, S Popilskis, S Homma, M Packer, J Wang.   

Abstract

Endothelial dysfunction in coronary circulation is well documented in heart failure (HF). However, whether this dysfunction is a consequence of heart failure or precedes the development of HF remains unknown. To determine endothelium-dependent regulation in the remote coronary vasculature in a canine coronary microembolization-induced HF model, seven dogs were chronically instrumented for measurement of systemic hemodynamics, for selective coronary microembolization via an implanted coronary catheter and for measurement of coronary blood flow in the non-embolized coronary artery. Microembolizations were performed daily until hemodynamic and echocardiographic measurements showed HF. The responses of coronary blood flow to acetylcholine (0.25, 0.5, 5, 10 microg/kg), nitroglycerin (0.2, 0.8, 5, 25 microg/kg), adenosine (0.25, 0.5, 2, 5 micromol/kg) and brief coronary occlusions (5, 10, 15, 20, 30 s) were examined. Although no signs of HF developed and the responses of coronary blood flow to nitroglycerin, adenosine and occlusions were not altered, the response to acetylcholine was selectively reduced after 1 week of embolization (275,000+/-55,000 microspheres). Resting coronary flow increased from 21.3+/-1.4 ml/min in control state to 27.7+3.5 ml/min (P<0.001). As HF developed, characterized by an elevated left ventricular end-diastolic pressure (6.4+/-1.6 v 16+/-1.6 mmHg, P<0.001), a decreased area ejection fraction (54+/-5 v 36+/-5%, P<0.05) and a reduced beta-adrenergic response to isoproterenol, the responses of coronary blood flow to acetylcholine, nitroglycerine, adenosine and occlusions were consistently depressed. Resting coronary blood flow was decreased to 15.4+/-2.7 ml/min (P<0.01). Our results indicate, that there is a selectively impaired endothelium-mediated dilator capacity of the resistance coronary vasculature before the development of HF and a reduction of the coronary flow reserve.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040036     DOI: 10.1006/jmcc.1996.0266

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  9 in total

1.  Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.

Authors:  Suresh Selvaraj Palaniyandi; Koichi Inagaki; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2008-09-04       Impact factor: 5.000

2.  Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy.

Authors:  Susan P Bell; Douglas W Adkisson; Henry Ooi; Douglas B Sawyer; Mark A Lawson; Marvin W Kronenberg
Journal:  J Card Fail       Date:  2013-10-29       Impact factor: 5.712

3.  MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.

Authors:  Jordan D Miller; Veronica A Peotta; Yi Chu; Robert M Weiss; Kathy Zimmerman; Robert M Brooks; Donald D Heistad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-03-19       Impact factor: 4.733

4.  Sustained left ventricular diastolic dysfunction after exercise in patients with dilated cardiomyopathy.

Authors:  M Morikawa; H Sato; H Sato; Y Koretsune; Y Ohnishi; T Kurotobi; T Kuzuya; M Hori
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

5.  Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.

Authors:  Isaac George; Brad Morrow; Kai Xu; Geng-Hua Yi; Jeffrey Holmes; Ed X Wu; Zhihe Li; Andrew A Protter; Mehmet C Oz; Jie Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

6.  Circulating endothelial cells as biomarker for cardiovascular diseases.

Authors:  Maura Farinacci; Thomas Krahn; Wilfried Dinh; Hans-Dieter Volk; Hans-Dirk Düngen; Josephine Wagner; Timo Konen; Oliver von Ahsen
Journal:  Res Pract Thromb Haemost       Date:  2018-10-26

Review 7.  Coronary blood flow in heart failure: cause, consequence and bystander.

Authors:  Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2022-01-13       Impact factor: 12.416

8.  Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy.

Authors:  Susan P Bell; Douglas W Adkisson; Mark A Lawson; Li Wang; Henry Ooi; Douglas B Sawyer; Marvin W Kronenberg
Journal:  J Am Heart Assoc       Date:  2014-08-27       Impact factor: 5.501

9.  Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice.

Authors:  Han Su; Heng Zeng; Xiaochen He; Shai-Hong Zhu; Jian-Xiong Chen
Journal:  J Am Heart Assoc       Date:  2020-08-31       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.